BioMarin Pharmaceutical | BMRN - 销售成本

股票价格

54.56

每天变化

-0.47 -0.85%

每月一次

-13.29%

每年

-23.41%

Q1 预测

56.74

金融业

USD

USD 7.59B

现金及等价物

USD 1.31B

USD 161.56M

USD 3.95B

USD 759.03M

USD 604.24M

USD 198.39M

USD -24.17M

3.04K

EPS每股收益

USD 0.46

股本和储备

USD 6.09B

USD 713.01M

债务利息支出

USD 2.78M

USD 17.85M

USD 597.18M

USD 10.47B

USD -46.57M

USD 676.18M

USD 198.39M

普通股股本

USD 192.3M

19.24

USD -26.32M

USD 875M

销售和管理费用

USD 322.21M

USD 1.3B

贸易债权人

USD 759.03M

应收帐款人

USD 908.21M

	销售成本	更改		日
Acadia Pharmaceuticals	USD 26.22M		4.58M	2025-12
Agios Pharmaceuticals	USD 1.88M		199K	2025-12
Alnylam Pharmaceuticals	USD 267.72M		67.57M	2025-12
Amgen	USD 1.79B		128M	2025-12
Bayer	EUR 4.5B		194M	2025-12
Biogen	USD 810.1M		205.1M	2025-09
BioMarin Pharmaceutical	USD 161.56M		16.62M	2025-12
Gilead Sciences	USD 1.62B		50M	2025-12
Incyte	USD 121.18M		22.18M	2025-12
Insmed	USD 46.16M		15.25M	2025-12
Ionis Pharmaceuticals	USD 8M		5.66M	2025-12
Moderna	USD 452M		245M	2025-12
Neurocrine Biosciences	USD 17.6M		246.4M	2025-12
PTC Therapeutics	USD 16.3M		7.02M	2025-12
Puma Biotechnology	USD 29.1M		18.44M	2024-09
Regeneron Pharmaceuticals	USD 584.6M		63M	2025-12
Roche Holding	CHF 8.48B		4.61B	2025-12
Sangamo BioSciences	2.42M		1.11M	2024-06
Sanofi	EUR 3.76B		344M	2025-12
Sarepta Therapeutics	USD 399.38M		247.93M	2025-12
Ultragenyx Pharmaceutical	USD 29M		1.01M	2025-12
United Therapeutics	USD 474.7M		373.8M	2025-12
Vertex Pharmaceuticals	USD 466M		51.2M	2025-12